We are live on
!
Find out more
Group One Trading Portfolio holdings
AUM
$52.2B
1-Year Est. Return
104.56%
This Fund
S&P 500
This Quarter
Est. Return
-6.28%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,999.92%
AUM
$34.5B
AUM Growth
-$9.22B
(-21%)
Cap. Flow
-$7.24B
Cap. Flow
% of AUM
-20.99%
Top 10 Holdings %
Top 10 Hldgs %
18.89%
Holding
8,640
New
1,474
Increased
2,846
Reduced
2,852
Closed
1,160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arm
ARM
|
+$49.7M |
| 2 |
Robinhood
HOOD
|
+$25.4M |
| 3 |
Newmont
NEM
|
+$24.6M |
| 4 |
NextEra Energy
NEE
|
+$24.3M |
| 5 |
Micron Technology
MU
|
+$20.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Madrigal Pharmaceuticals
MDGL
|
+$32.9M |
| 2 |
Eli Lilly
LLY
|
+$31M |
| 3 |
GXO Logistics
GXO
|
+$30.4M |
| 4 |
Wells Fargo
WFC
|
+$29.7M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$22.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.54% |
| 2 | Financials | 0.95% |
| 3 | Healthcare | 0.88% |
| 4 | Consumer Discretionary | 0.66% |
| 5 | Industrials | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6651
AngioDynamics
ANGO
$649M
| $4.98K | ﹤0.01% |
+530
| New | +$5.57K |
|
|
WOW
6652
PUT
DELISTED
WideOpenWest
WOW
| $4.95K | ﹤0.01% |
1,000
-12,200
| -92% | -$56.1K |
|
6653
PUT
Artivion
AORT
$1.32B
| $4.92K | ﹤0.01% |
+200
| New | +$5.55K |
|
6654
CALL
Acurx Pharmaceuticals
ACXP
$6.62M
| $4.91K | ﹤0.01% |
630
+95
| +18% | +$1.28K |
|
|
CMCT
6655
CALL
Creative Media & Community Trust
CMCT
$13M
| $4.91K | ﹤0.01% |
+8
| New | +$14.5K |
|
6656
CALL
V2X
VVX
$2.65B
| $4.91K | ﹤0.01% |
100
-800
| -89% | -$39.2K |
|
6657
Vulcan Materials
VMC
$36.9B
| $4.9K | ﹤0.01% |
+21
| New | +$5.33K |
|
6658
CALL
Consolidated Water Co
CWCO
$488M
| $4.9K | ﹤0.01% |
200
-2,400
| -92% | -$63.9K |
|
|
ISPO
6659
DELISTED
Inspirato
ISPO
| $4.89K | ﹤0.01% |
1,182
| – | – |
|
6660
IBEX
IBEX
$499M
| $4.87K | ﹤0.01% |
+200
| New | +$4.8K |
|
6661
PUT
Karyopharm Therapeutics
KPTI
$48M
| $4.86K | ﹤0.01% |
1,300
+1,213
| +1,394% | +$10.4K |
|
|
ARDT
6662
Ardent Health
ARDT
$1.66B
| $4.85K | ﹤0.01% |
353
| – | – |
|
|
TOUR
6663
CALL
Tuniu
TOUR
$55.6M
| $4.84K | ﹤0.01% |
440
-50
| -10% | -$515 |
|
6664
PTC
PTC
$16B
| $4.8K | ﹤0.01% |
+31
| New | +$5.33K |
|
|
MURA
6665
PUT
DELISTED
Mural Oncology
MURA
| $4.79K | ﹤0.01% |
3,800
+2,800
| +280% | +$10.2K |
|
6666
Inovio Pharmaceuticals
INO
$69M
| $4.77K | ﹤0.01% |
2,924
-9,446
| -76% | -$19K |
|
6667
PUT
POSCO
PKX
$17.5B
| $4.75K | ﹤0.01% |
100
| – | – |
|
6668
iShares MSCI Singapore ETF
EWS
$1.08B
| $4.75K | ﹤0.01% |
200
| – | – |
|
|
MRSN
6669
CALL
DELISTED
Mersana Therapeutics
MRSN
| $4.75K | ﹤0.01% |
552
-2,388
| -81% | -$36.8K |
|
6670
PUT
NeoGenomics
NEO
$2.13B
| $4.75K | ﹤0.01% |
+500
| New | +$6.24K |
|
6671
PUT
Universal Insurance Holdings
UVE
$1.23B
| $4.74K | ﹤0.01% |
200
| – | – |
|
6672
PUT
Larimar Therapeutics
LRMR
$432M
| $4.73K | ﹤0.01% |
2,200
-39,100
| -95% | -$124K |
|
6673
PUT
Virco
VIRC
$96.3M
| $4.73K | ﹤0.01% |
+500
| New | +$5.21K |
|
|
OLPX
6674
DELISTED
Olaplex Holdings
OLPX
| $4.72K | ﹤0.01% |
3,715
-13,000
| -78% | -$19.2K |
|
6675
CALL
Sphere 3D
ANY
$16M
| $4.7K | ﹤0.01% |
1,180
-190
| -14% | -$1.41K |
|
Similar funds
SCP
Group One Trading's Q1 2025 Portfolio in Review
As of Q1 2025, Group One Trading held 8,640 positions worth $34.5B, down 21% from $43.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Group One Trading withdrew a net $7.24B in Q1 2025, closing 1,160 positions and reducing 2,852 holdings. Its most notable exit was Madrigal Pharmaceuticals, an estimated $32.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.5% of assets, up from 1.4% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Group One Trading opened a new position in Arm worth $38M.
- Group One Trading's largest Q1 2025 buy was Arm: 356,137 shares worth $38M.
- Group One Trading added most to Robinhood in Q1 2025, an estimated $25.4M increase.
- Group One Trading's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $31M.
- Group One Trading fully exited Madrigal Pharmaceuticals in Q1 2025, selling an estimated $32.9M.
- Group One Trading's ten largest holdings make up 19% of its $34.5B portfolio in Q1 2025.
- Group One Trading opened 1,474 new positions and closed 1,160 in Q1 2025.
- Group One Trading's portfolio value fell 21% quarter-over-quarter to $34.5B.
Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.